107.59
2.49 (2.36%)
| Previous Close | 105.11 |
| Open | 103.65 |
| Volume | 1,124,160 |
| Avg. Volume (3M) | 984,067 |
| Market Cap | 7,004,763,136 |
| Price / Earnings (TTM) | 25.08 |
| Price / Earnings (Forward) | 18.69 |
| Price / Sales | 4.59 |
| Price / Book | 5.69 |
| 52 Weeks Range | |
| Earnings Date | 5 Aug 2026 |
| Profit Margin | 16.55% |
| Operating Margin (TTM) | 27.38% |
| Diluted EPS (TTM) | 3.51 |
| Quarterly Revenue Growth (YOY) | 0.80% |
| Quarterly Earnings Growth (YOY) | -44.30% |
| Total Debt/Equity (MRQ) | 52.78% |
| Current Ratio (MRQ) | 5.74 |
| Operating Cash Flow (TTM) | 525.08 M |
| Levered Free Cash Flow (TTM) | 241.87 M |
| Return on Assets (TTM) | 14.39% |
| Return on Equity (TTM) | 24.11% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Bullish |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | Lantheus Holdings, Inc. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -3.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.5 |
| Average | -0.83 |
|
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Growth |
| % Held by Insiders | 2.24% |
| % Held by Institutions | 116.12% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |